Ignite Creation Date:
2024-07-17 @ 11:51 AM
Last Modification Date:
2024-10-26 @ 3:33 PM
Study NCT ID:
NCT06478043
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-07-08
First Post:
2024-06-21
Brief Title:
A Study to Investigate the Efficacy and Safety of Ivonescimab Combined With Irinotecan Liposome as Second-line Regimen for ES-SCLC
Sponsor:
Zhejiang Cancer Hospital
Organization:
Zhejiang Cancer Hospital
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Extensive-stage Small-cell Lung Cancer |
Keywords: